New drug approval process: the global challenge
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Dekker
2000
|
| Ausgabe: | 3. ed. |
| Schriftenreihe: | Drugs and the pharmaceutical sciences
100 |
| Schlagworte: | |
| Beschreibung: | XXXIII, 471 S. |
| ISBN: | 0824703081 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012986340 | ||
| 003 | DE-604 | ||
| 005 | 20170831 | ||
| 007 | t | ||
| 008 | 000214s2000 |||| 00||| eng d | ||
| 020 | |a 0824703081 |9 0-8247-0308-1 | ||
| 035 | |a (OCoLC)42429707 | ||
| 035 | |a (DE-599)BVBBV012986340 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-19 | ||
| 050 | 0 | |a RS189 | |
| 082 | 0 | |a 363.19/46/0973 |2 21 | |
| 084 | |a VR 2520 |0 (DE-625)147656: |2 rvk | ||
| 245 | 1 | 0 | |a New drug approval process |b the global challenge |c ed. by Richard A. Guarino |
| 250 | |a 3. ed. | ||
| 264 | 1 | |a New York [u.a.] |b Dekker |c 2000 | |
| 300 | |a XXXIII, 471 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drugs and the pharmaceutical sciences |v 100 | |
| 650 | 4 | |a Médicaments - Essais cliniques - Normes | |
| 650 | 4 | |a Médicaments - Essais cliniques - Politique gouvernementale - États-Unis | |
| 650 | 4 | |a Produits nouveaux - Politique gouvernementale - États-Unis | |
| 650 | 4 | |a Politik | |
| 650 | 4 | |a Clinical Trials as Topic |x standards |z United States | |
| 650 | 4 | |a Drug Evaluation |x standards |z United States | |
| 650 | 4 | |a Drug approval |z United States | |
| 650 | 4 | |a Drugs |x Testing |x Government policy |z United States | |
| 650 | 4 | |a Drugs |x Testing |x Standards | |
| 650 | 4 | |a New products |x Government policy |z United States | |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 0 | 3 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Guarino, Richard A. |d 1935- |e Sonstige |0 (DE-588)139424458 |4 oth | |
| 830 | 0 | |a Drugs and the pharmaceutical sciences |v 100 |w (DE-604)BV000002008 |9 100 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008847364 | ||
Datensatz im Suchindex
| _version_ | 1804127682956361728 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)139424458 |
| building | Verbundindex |
| bvnumber | BV012986340 |
| callnumber-first | R - Medicine |
| callnumber-label | RS189 |
| callnumber-raw | RS189 |
| callnumber-search | RS189 |
| callnumber-sort | RS 3189 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | VR 2520 |
| ctrlnum | (OCoLC)42429707 (DE-599)BVBBV012986340 |
| dewey-full | 363.19/46/0973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 363 - Other social problems and services |
| dewey-raw | 363.19/46/0973 |
| dewey-search | 363.19/46/0973 |
| dewey-sort | 3363.19 246 3973 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Chemie / Pharmazie Soziologie |
| edition | 3. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02160nam a2200577 cb4500</leader><controlfield tag="001">BV012986340</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20170831 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">000214s2000 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824703081</subfield><subfield code="9">0-8247-0308-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)42429707</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012986340</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS189</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">363.19/46/0973</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VR 2520</subfield><subfield code="0">(DE-625)147656:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New drug approval process</subfield><subfield code="b">the global challenge</subfield><subfield code="c">ed. by Richard A. Guarino</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXXIII, 471 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">100</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Essais cliniques - Normes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Essais cliniques - Politique gouvernementale - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Produits nouveaux - Politique gouvernementale - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Politik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="x">standards</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug approval</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Standards</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">New products</subfield><subfield code="x">Government policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guarino, Richard A.</subfield><subfield code="d">1935-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)139424458</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">100</subfield><subfield code="w">(DE-604)BV000002008</subfield><subfield code="9">100</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008847364</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV012986340 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:37:14Z |
| institution | BVB |
| isbn | 0824703081 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008847364 |
| oclc_num | 42429707 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-19 DE-BY-UBM |
| physical | XXXIII, 471 S. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Dekker |
| record_format | marc |
| series | Drugs and the pharmaceutical sciences |
| series2 | Drugs and the pharmaceutical sciences |
| spelling | New drug approval process the global challenge ed. by Richard A. Guarino 3. ed. New York [u.a.] Dekker 2000 XXXIII, 471 S. txt rdacontent n rdamedia nc rdacarrier Drugs and the pharmaceutical sciences 100 Médicaments - Essais cliniques - Normes Médicaments - Essais cliniques - Politique gouvernementale - États-Unis Produits nouveaux - Politique gouvernementale - États-Unis Politik Clinical Trials as Topic standards United States Drug Evaluation standards United States Drug approval United States Drugs Testing Government policy United States Drugs Testing Standards New products Government policy United States Arzneimittel (DE-588)4003115-9 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Zulassung (DE-588)4127410-6 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content USA (DE-588)4078704-7 g Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s Gesundheitspolitik (DE-588)4113743-7 s DE-604 Guarino, Richard A. 1935- Sonstige (DE-588)139424458 oth Drugs and the pharmaceutical sciences 100 (DE-604)BV000002008 100 |
| spellingShingle | New drug approval process the global challenge Drugs and the pharmaceutical sciences Médicaments - Essais cliniques - Normes Médicaments - Essais cliniques - Politique gouvernementale - États-Unis Produits nouveaux - Politique gouvernementale - États-Unis Politik Clinical Trials as Topic standards United States Drug Evaluation standards United States Drug approval United States Drugs Testing Government policy United States Drugs Testing Standards New products Government policy United States Arzneimittel (DE-588)4003115-9 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd |
| subject_GND | (DE-588)4003115-9 (DE-588)4113743-7 (DE-588)4127410-6 (DE-588)4078704-7 (DE-588)4143413-4 |
| title | New drug approval process the global challenge |
| title_auth | New drug approval process the global challenge |
| title_exact_search | New drug approval process the global challenge |
| title_full | New drug approval process the global challenge ed. by Richard A. Guarino |
| title_fullStr | New drug approval process the global challenge ed. by Richard A. Guarino |
| title_full_unstemmed | New drug approval process the global challenge ed. by Richard A. Guarino |
| title_short | New drug approval process |
| title_sort | new drug approval process the global challenge |
| title_sub | the global challenge |
| topic | Médicaments - Essais cliniques - Normes Médicaments - Essais cliniques - Politique gouvernementale - États-Unis Produits nouveaux - Politique gouvernementale - États-Unis Politik Clinical Trials as Topic standards United States Drug Evaluation standards United States Drug approval United States Drugs Testing Government policy United States Drugs Testing Standards New products Government policy United States Arzneimittel (DE-588)4003115-9 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Zulassung (DE-588)4127410-6 gnd |
| topic_facet | Médicaments - Essais cliniques - Normes Médicaments - Essais cliniques - Politique gouvernementale - États-Unis Produits nouveaux - Politique gouvernementale - États-Unis Politik Clinical Trials as Topic standards United States Drug Evaluation standards United States Drug approval United States Drugs Testing Government policy United States Drugs Testing Standards New products Government policy United States Arzneimittel Gesundheitspolitik Zulassung USA Aufsatzsammlung |
| volume_link | (DE-604)BV000002008 |
| work_keys_str_mv | AT guarinoricharda newdrugapprovalprocesstheglobalchallenge |